Search news

Browse by category


Select all - Clear all

Former Dean Dr Geoff Vaughan passes away

Dr Geoffrey Vaughan AO, who was Dean of the Victorian College of Pharmacy (“VCP”) from 1979 to 1986, passed away peacefully on 4 January, 2018. He was aged 84.

University news

Monash Research Fellow wins Pharmacist of the Year Award

The Pharmaceutical Society of Australia SA/NT has presented the 2018 Pharmacist of the Year Award to Dr Janet Sluggett, a Research Fellow at the Centre for Medicine Use and Safety (“CMUS”) at Monash University.

Monash University retains #2 world ranking in Pharmacy and Pharmacology

The 2018 QS World University Rankings by Subject, released overnight, have ranked Monash University second in the world for pharmacy and pharmacology. This is a repeat of the 2017 World University rankings, in which Monash also ranked second.

First hormone-free male pill soon to be a reality

A hormone-free male pill may soon become a reality, with Monash scientists moving closer to developing a new combination of oral contraceptive drugs that together block the transport of sperm during ejaculation.

Professor Arthur Christopoulos appointed as Theme Leader Drug Discovery Biology at MIPS

Effective from March 15, 2018, Professor Arthur Christopoulos will become Theme Leader, Drug Discovery Biology, at the Monash Institute of Pharmaceutical Sciences (MIPS).


Breakthrough could lead to better drugs to tackle diabetes and obesity

Breakthrough research at Monash University has shown how different areas of major diabetes and obesity drug targets can be ‘activated’, guiding future drug development and better treatment of diseases.

Medicine & health
Jessica Bailey

Monash Pharmacy student awarded prestigious scholarship

Monash University Pharmacy student Jessica Bailey has been awarded the prestigious Academy for Emerging Leaders in Patient Safety Scholarship.

Medicine & health
Associate Professor Bernard Flynn

From lab to industry, Monash-linked start up attracts $7M investment

Drug discovery research at Monash has underpinned a new spin out company to develop therapies for metabolic syndrome and type-2 diabetes-related diseases.

Medicine & health